Country | ||||
---|---|---|---|---|
Overall | US | Israel | ||
N = 2,222 | N = 1,128 | N = 1,094 | ||
(100%) | (50.8%) | (49.2%) | ||
Variables | N (%) or M (SD) | N (%) or M (SD) | N (%) or M (SD) | p |
Sociodemographics | – | – | – | – |
Age, M (SD) | 32.19 (7.74) | 34.11 (7.23) | 30.21 (7.76) | < .001 |
Female, N (%) | 1,118 (50.3) | 562 (49.8) | 556 (50.8) | .637 |
Sexual minority, N (%) | 356 (16.0) | 147 (13.0) | 209 (19.1) | < .001 |
≥ College degree, N (%) | 953 (42.9) | 484 (42.9) | 469 (42.9) | .986 |
Married/cohabitating, N (%) | 1,186 (53.4) | 601 (53.3) | 585 (53.5) | .927 |
Children in the home, N (%) | 1,125 (50.6) | 529 (46.9) | 596 (54.5) | < .001 |
Theory-based predictors, M (SD) | ||||
Perceived risk – mean score a | 4.75 (1.97) | 4.29 (1.99) | 5.18 (1.84) | < .001 |
Addictiveness | 4.76 (2.25) | 4.40 (2.26) | 5.12 (2.19) | < .001 |
Harm to health | 4.73 (2.20) | 4.20 (2.22) | 5.25 (2.05) | < .001 |
Perceived social norms – mean score b | 2.49 (1.60) | 2.79 (1.70) | 2.19 (1.44) | < .001 |
Social acceptability | 2.58 (1.90) | 2.93 (2.04) | 2.24 (1.69) | < .001 |
Use in social network | 2.40 (1.68) | 2.64 (1.70) | 2.15 (1.61) | < .001 |
N = 809 | N = 563 | N = 246 | ||
Those reporting lifetime cannabis use: | (36.4%) | (49.9%) | (22.5%) | < .001 |
Age of first use, M (SD) | 18.28 (5.83) | 17.83 (5.22) | 19.31 (6.95) | .001 |
Methods used, past 12 months, N (%) | ||||
Smoked without tobacco | 244 (30.2) | 202 (36.0) | 42 (17.2) | < .001 |
Smoked with tobacco | 167 (20.7) | 48 (8.6) | 119 (48.4) | < .001 |
Vaped in liquid form | 140 (17.3) | 109 (19.4) | 31 (12.6) | .018 |
Vaped dried leaves or herb | 59 (7.3) | 34 (6.1) | 25 (10.2) | .039 |
Dabbed concentrates (e.g., shatter, budder, wax) | 59 (7.3) | 50 (8.9) | 9 (3.7) | .008 |
Orally (e.g., oil, capsules, dissolvable strips, spray) | 51 (6.3) | 38 (6.8) | 13 (5.3) | .424 |
Topically (e.g., lotions, bath salts) | 39 (4.8) | 28 (5.0) | 11 (4.5) | .751 |
Edibles (i.e., food/drinks) | 178 (22.1) | 152 (27.1) | 26 (10.6) | < .001 |
Primary reasons for cannabis use, N (%)c | .015 | |||
Recreational purposes | 479 (66.3) | 345 (68.5) | 134 (61.2) | |
Medical purposes | 66 (9.1) | 36 (7.1) | 30 (13.7) | |
Both recreational and medical purposes | 178 (24.6) | 123 (24.4) | 55 (25.1) | |
Source of cannabis, most often in past 12 months, N (%)d | < .001 | |||
Family member or friend | 184 (41.7) | 119 (41.5) | 65 (42.2) | |
Dealer or other non-legal source (in person) | 91 (20.6) | 52 (18.1) | 39 (25.3) | |
At vape shop, dispensary, co-operative, or other store | 100 (22.7) | 91 (31.7) | 9 (5.8) | |
Online | 66 (15.0) | 25 (8.7) | 41 (26.6) | |
N = 370 | N = 248 | N = 122 | ||
Those reporting past 30-day cannabis use: | (16.7%) | (22.0%) | (11.2%) | < .001 |
Number of days used, past 30 days, M (SD) | 13.84 (11.85) | 15.90 (12.29) | 9.66 (9.67) | < .001 |
Times used per day on days used, M (SD) | 3.29 (2.89) | 3.26 (3.00) | 3.37 (2.69) | .728 |
Most common method, past 12 months, N (%) | < .001 | |||
Smoked without tobacco | 123 (34.3) | 113 (47.3) | 10 (8.3) | |
Smoked with tobacco | 94 (26.2) | 25 (10.5) | 69 (57.5) | |
Vaped | 75 (20.9) | 47 (19.7) | 28 (23.3) | |
Edibles (i.e., food/drinks) | 28 (7.8) | 27 (11.3) | 1 (0.8) | |
Other | 39 (10.9) | 27 (11.3) | 12 (10.0) |